Ambu A/S banner

Ambu A/S
OTC:AMBFF

Watchlist Manager
Ambu A/S Logo
Ambu A/S
OTC:AMBFF
Watchlist
Price: 13.65 USD Market Closed
Market Cap: $3.6B

P/S

2.5
Current
49%
Cheaper
vs 3-y average of 5

Price to Sales (P/S) ratio shows how much investors pay for each dollar of a company`s sales. It`s calculated by dividing the company`s market value by its total revenue.

P/S
2.5
=
Market Cap
$18.4B
/
Revenue
kr6.1B

Price to Sales (P/S) ratio shows how much investors pay for each dollar of a company`s sales. It`s calculated by dividing the company`s market value by its total revenue.

P/S
2.5
=
Market Cap
$18.4B
/
Revenue
kr6.1B

Valuation Scenarios

Ambu A/S is trading below its 3-year average

If P/S returns to its 3-Year Average (5), the stock would be worth $26.94 (97% upside from current price).

Statistics
Positive Scenarios
3/4
Maximum Downside
-24%
Maximum Upside
+108%
Average Upside
46%
Scenario P/S Value Implied Price Upside/Downside
Current Multiple 2.5 $13.65
0%
3-Year Average 5 $26.94
+97%
5-Year Average 5.2 $28.35
+108%
Industry Average 2.6 $14.05
+3%
Country Average 1.9 $10.31
-24%

Forward P/S
Today’s price vs future revenue

Today's Market Cap Revenue Forward P/S
$18.4B
/
Jan 2026
kr6.1B
=
2.5
Current
$18.4B
/
Sep 2026
kr6.6B
=
2.8
Forward
$18.4B
/
Sep 2027
kr7.3B
=
2.5
Forward
$18.4B
/
Sep 2028
kr8.2B
=
2.2
Forward
$18.4B
/
Sep 2029
kr9.2B
=
2
Forward
$18.4B
/
Sep 2030
kr10.2B
=
1.8
Forward
$18.4B
/
Sep 2031
kr11.6B
=
1.6
Forward

Forward P/S shows whether today’s P/S still looks high or low once future revenue are taken into account.

Peer Comparison

All Multiples
P/S
P/E
All Countries
Close
Market Cap P/S P/E
DK
Ambu A/S
OTC:AMBFF
15.2B USD 2.5 28.2
US
Intuitive Surgical Inc
NASDAQ:ISRG
161.2B USD 16 56.4
US
Abbott Laboratories
NYSE:ABT
158.6B USD 3.5 25.3
US
Stryker Corp
NYSE:SYK
120.5B USD 4.8 37.1
IE
Medtronic PLC
NYSE:MDT
101.9B USD 2.9 22.1
US
Boston Scientific Corp
NYSE:BSX
84.8B USD 4.1 23.8
US
Edwards Lifesciences Corp
NYSE:EW
47.2B USD 7.5 43
US
IDEXX Laboratories Inc
NASDAQ:IDXX
44.1B USD 10.3 41.7
DE
Siemens Healthineers AG
XETRA:SHL
38.3B EUR 1.7 18.1
US
Becton Dickinson and Co
NYSE:BDX
41.4B USD 1.9 23.5
US
Resmed Inc
NYSE:RMD
30.9B USD 5.7 20.8

Market Distribution

Lower than 89% of companies in Denmark
Percentile
11th
Based on 438 companies
11th percentile
0.5
Low
0.1 — 1.3
Typical Range
1.3 — 3.5
High
3.5 —
Distribution Statistics
Denmark
Min 0.1
30th Percentile 1.3
Median 1.9
70th Percentile 3.5
Max 37.5

Ambu A/S
Glance View

Market Cap
3.6B USD
Industry
Health Care

Ambu A/S, a Danish company rooted in innovation, has carved a niche in the global healthcare sector through its specialized medical devices. Founded in 1937, Ambu started with a simple mission of improving patient care and has stayed true to that vision by continuously advancing their portfolio. The company's journey began with the invention of the resuscitator bag, a revolutionary product that remains a staple in emergency and hospital settings today. Over the years, Ambu has focused strategically on three main segments: Anesthesia, Patient Monitoring & Diagnostics, and Visualisation, each playing a crucial role in the broader healthcare ecosystem. These segments allow Ambu to develop devices that enhance diagnostic procedures, improve safety, and increase efficiency in medical settings, ultimately saving lives and optimizing healthcare delivery. Ambu’s business model capitalizes primarily on innovation-driven sales, with a strong emphasis on disposable medical devices which are gaining popularity due to hygiene concerns and regulatory trends favoring single-use technologies. These products include their flagship single-use endoscopes, marketed under the brand name "Ambu aScope," which significantly reduce the risk of cross-contamination while providing high-quality diagnostic images. The company's revenue model is built on a B2B approach, dealing directly with hospitals, clinics, and other healthcare providers, ensuring a steady flow of sales through long-term contracts and partnerships. Through constant reinvestment into R&D and strategic acquisitions, Ambu sustains its market leadership, driving growth by addressing the evolving needs of the healthcare industry and setting standards in patient care solutions globally.

AMBFF Intrinsic Value
17.89 USD
Undervaluation 24%
Intrinsic Value
Price $13.65
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett